FRONTEO,Inc. (2158) Other
Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Return on Assets | - | - | - | - | -0.9 | -0.1 | 3.5 | 0.5 | 0.9 | 3.3 | 11 | -6 | -26.2 | 7.9 |
| Return on equity (%) | - | - | - | |||||||||||
| Employees | 111 | 149 | 160 | 191 | 423 | 486 | 362 | 387 | 335 | 315 | 310 | 288 | 225 | 206 |